Botanix Pharmaceuticals Limited (BOT) Stock Statistics & Valuation Metrics

Botanix Pharmaceuticals Limited has a market cap or net worth of AUD 24.86M. The enterprise value is AUD 34.48M.

Market Cap

AUD 24.86M

Enterprise Value

AUD 34.48M

Botanix Pharmaceuticals Limited has 2,762,671,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,762,671,100

Owned by Insiders

2.05%

Owned by Institutions

<0.01%

Botanix Pharmaceuticals Limited’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -77.62%.

Return on Equity (ROE)

-1.10

Return on Assets (ROA)

-0.66

Return on Invested Capital (ROIC)

-77.62%

Return on Capital Employed (ROCE)

-0.92

Revenue Per Employee

3.14M

Profits Per Employee

-6.34M

Employee Count

11

Asset Turnover

0.33

Inventory Turnover

3.00

The current PE Ratio of Botanix Pharmaceuticals Limited is -0.28. Botanix Pharmaceuticals Limited’s PEG ratio is -0.01.

PE Ratio

-0.28

PS Ratio

0.52

PB Ratio

0.34

Price to FCF

-0.28

Price to Operating Cash Flow

-0.33

PEG Ratio

-0.01

In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 34.51M and earned -69.77M in profits. Earnings per share was -0.03.

Revenue

34.51M

Gross Profit

-59.43M

Operating Income

-69.31M

Pretax Income

-69.77M

Net Income

-69.77M

EBITDA

-69.31M

Earnings Per Share (EPS)

-0.03

In the last 12 months, operating cash flow was -64.60M and capital expenditures 4, giving a free cash flow of -64.60M billion.

Operating Cash Flow

-64.60M

Free Cash Flow

-64.60M

Free Cash Flow per Share

-0.03

Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-360.22%

Earnings Yield

-324.86%

Beta

1.05

52-Week Price Change

-92.31%

50-Day Moving Average

0.02

200-Day Moving Average

0.03

Relative Strength Index (RSI)

33.47

Average Volume (3m)

7.68M

Botanix Pharmaceuticals Limited upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

Mar 03, 2027

Ex-Dividend Date

―

Botanix Pharmaceuticals Limited as a current ratio of 2.59, with Debt / Equity ratio of 23.21%

Current Ratio

2.59

Quick Ratio

1.58

Debt to Market Cap

0.35

Net Debt to EBITDA

0.32

Interest Coverage Ratio

-24.43

In the past 12 months, Botanix Pharmaceuticals Limited has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Botanix Pharmaceuticals Limited EV to EBITDA ratio is 0.06, with an EV/FCF ratio of 0.06.

EV to Sales

-0.11

EV to EBITDA

0.06

EV to Free Cash Flow

0.06

EV to Operating Cash Flow

0.06

Botanix Pharmaceuticals Limited has AUD 36.63M in cash and marketable securities with AUD 14.74M in debt, giving a net cash position of AUD 21.89M billion.

Cash & Marketable Securities

AUD 36.63M

Total Debt

AUD 14.74M

Net Cash

AUD 21.89M

Net Cash Per Share

AUD 0.01

Tangible Book Value Per Share

AUD 0.02

Gross margin is -172.20%, with operating margin of -200.82%, and net profit margin of -202.15%.

Gross Margin

-172.20%

Operating Margin

-200.82%

Pretax Margin

-202.15%

Net Profit Margin

-202.15%

EBITDA Margin

-197.39%

EBIT Margin

-200.82%

The average price target for Botanix Pharmaceuticals Limited is AUD 0.51, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

AUD 0.51

Price Target Upside

4950.00% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

499.47%

EPS Growth Forecast

31.20%

Smart Score

6

AI Score

42